{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:52:28Z","timestamp":1760151148940,"version":"build-2065373602"},"reference-count":140,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"New Jersey Comission on Cancer Research","award":["DCSH20PPC04"],"award-info":[{"award-number":["DCSH20PPC04"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Endometrial cancer is the most common gynecological cancer, representing 3.5% of all new cancer cases in the United States. Abnormal stem cell-like cells, referred to as cancer stem cells (CSCs), reside in the endometrium and possess the capacity to self-renew and differentiate into cancer progenitors, leading to tumor progression. Herein we review the role of the endometrial microenvironment and sex hormone signaling in sustaining EC progenitors and potentially promoting dormancy, a cellular state characterized by cell cycle quiescence and resistance to conventional treatments. We offer perspective on mechanisms by which bone marrow-derived cells (BMDCs) within the endometrial microenvironment could promote endometrial CSC (eCSC) survival and\/or dormancy. Our perspective relies on the well-established example of another sex hormone-driven cancer, breast cancer, in which the BM microenvironment plays a crucial role in acquisition of CSC phenotype and dormancy. Our previous studies demonstrate that BMDCs migrate to the endometrium and express sex hormone (estrogen and progesterone) receptors. Whether the BM is a source of eCSCs is unknown; alternatively, crosstalk between BMDCs and CSCs within the endometrial microenvironment could be an additional mechanism supporting eCSCs and tumorigenesis. Elucidating these mechanisms will provide avenues to develop novel therapeutic interventions for EC.<\/jats:p>","DOI":"10.3390\/cells11040714","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:24:26Z","timestamp":1645129466000},"page":"714","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bone Marrow-Derived Cells in Endometrial Cancer Pathogenesis: Insights from Breast Cancer"],"prefix":"10.3390","volume":"11","author":[{"given":"Alejandra I.","family":"Ferrer","sequence":"first","affiliation":[{"name":"Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA"},{"name":"School of Graduate Studies Newark, Rutgers University, Newark, NJ 07103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Einstein","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara S.","family":"Morelli","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"ref_1","unstructured":"National Cancer Institute (2022, January 15). Cancer Stat Facts: Uterine Cancer 2021, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.15585\/mmwr.mm6748a1","article-title":"Uterine Cancer Incidence and Mortality\u2014United States, 1999\u20132016","volume":"67","author":"Henley","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial Cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Giannone, G., Attademo, L., Scotto, G., Genta, S., Ghisoni, E., Tuninetti, V., Aglietta, M., Pignata, S., and Valabrega, G. (2019). Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications. Cancers, 11.","DOI":"10.3390\/cancers11111820"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ogc.2012.04.001","article-title":"Endometrial cancer","volume":"39","author":"Leslie","year":"2012","journal-title":"Obs. Gynecol. Clin. North. Am."},{"key":"ref_6","unstructured":"Casey, M.J., Summers, G.K., and Crotzer, D. (2021). Endometrial Cancer, StatPearls Publishing LLC."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000475529","article-title":"Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences","volume":"85","author":"Gatius","year":"2018","journal-title":"Pathobiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer stem cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy","volume":"7","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/srep00906","article-title":"Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy","volume":"2","author":"Patel","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tempest, N., Maclean, A., and Hapangama, D.K. (2018). Endometrial Stem Cell Markers: Current Concepts and Unresolved Questions. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103240"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sahoo, S.S., Zhang, X.D., Hondermarck, H., and Tanwar, P.S. (2018). The Emerging Role of the Microenvironment in Endometrial Cancer. Cancers, 10.","DOI":"10.3390\/cancers10110408"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.fertnstert.2015.02.030","article-title":"Contribution of different bone marrow-derived cell types in endometrial regeneration using an irradiated murine model","volume":"103","author":"Cervello","year":"2015","journal-title":"Fertil Steril"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1095\/biolreprod.113.107987","article-title":"Experimental evidence for bone marrow as a source of nonhematopoietic endometrial stromal and epithelial compartment cells in a murine model","volume":"89","author":"Morelli","year":"2013","journal-title":"Biol. Reprod."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1634\/stemcells.2006-0828","article-title":"Contribution of bone marrow-derived stem cells to endometrium and endometriosis","volume":"25","author":"Du","year":"2007","journal-title":"Stem. Cells"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5653\/cerm.2018.45.4.149","article-title":"Bone marrow-derived stem cells contribute to regeneration of the endometrium","volume":"45","author":"Lee","year":"2018","journal-title":"Clin. Exp. Reprod. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-013-9422-z","article-title":"Dormancy in solid tumors: Implications for prostate cancer","volume":"32","author":"Ruppender","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: Have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_21","first-page":"886","article-title":"Comparison of Risk Factors and survival of Type 1 and Type II Endometrial Cancers","volume":"32","author":"Malik","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: More than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/GRF.0b013e318218c755","article-title":"Uterine papillary serous carcinoma","volume":"54","author":"Moore","year":"2011","journal-title":"Clin. Obs. Gynecol."},{"key":"ref_24","first-page":"63","article-title":"An update of the classical Bokhman\u2019s dualistic model of endometrial cancer","volume":"15","author":"Danielska","year":"2016","journal-title":"Prz Menopauzalny"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40661-016-0035-4","article-title":"New classification of endometrial cancers: The development and potential applications of genomic-based classification in research and clinical care","volume":"3","author":"Talhouk","year":"2016","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"ref_26","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Grossman, A., Hershman, J.M., and Hofland, J. (2000). The Normal Menstrual Cycle and the Control of Ovulation. Endotext, MDText.com, Inc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpobgyn.2020.05.003","article-title":"Progesterone and endometrial cancer","volume":"69","author":"Gompel","year":"2020","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/jwh.2018.6956","article-title":"Increased Incidence of Endometrial Cancer Following the Women\u2019s Health Initiative: An Assessment of Risk Factors","volume":"28","author":"Constantine","year":"2019","journal-title":"J. Womens Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment","volume":"34","author":"Onstad","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_30","first-page":"405","article-title":"Conservative treatment in early stage endometrial cancer: A review","volume":"90","author":"Trojano","year":"2019","journal-title":"Acta Biomed."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nakamura, M., Obata, T., Daikoku, T., and Fujiwara, H. (2019). The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215482"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PGP.0000000000000243","article-title":"TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers","volume":"35","author":"Schultheis","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/emmm.201101063","article-title":"p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans","volume":"4","author":"Wild","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"ref_34","first-page":"5952","article-title":"Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma","volume":"18","author":"Akiyama","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Obata, T., Nakamura, M., Mizumoto, Y., Iizuka, T., Ono, M., Terakawa, J., Daikoku, T., and Fujiwara, H. (2017). Dual expression of immunoreactive estrogen receptor beta and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188641"},{"key":"ref_36","first-page":"4575","article-title":"Expression of p53 and PTEN in human primary endometrial carcinomas: Clinicopathological and immunohistochemical analysis and study of their concomitant expression","volume":"17","author":"Stavropoulos","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/modpathol.3800347","article-title":"Immunohistochemical analysis of PTEN in endometrial carcinoma: A tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities","volume":"18","author":"Pallares","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0046-8177(00)80244-0","article-title":"PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases","volume":"31","author":"Bussaglia","year":"2000","journal-title":"Hum. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/cncr.10434","article-title":"Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma","volume":"94","author":"Salvesen","year":"2002","journal-title":"Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/onc.2017.326","article-title":"PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy","volume":"37","author":"Bian","year":"2018","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","article-title":"The biology of cancer stem cells","volume":"23","author":"Lobo","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_44","first-page":"1101","article-title":"Cancer stem cells: Implications for cancer therapy","volume":"28","author":"Dawood","year":"2014","journal-title":"Oncology"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Prieto-Vila, M., Takahashi, R.U., Usuba, W., Kohama, I., and Ochiya, T. (2017). Drug Resistance Driven by Cancer Stem Cells and Their Niche. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122574"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4614-1445-2_8","article-title":"Tumor dormancy and cancer stem.m cells: Two sides of the same coin?","volume":"734","author":"Kleffel","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Wicha","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell. Stem Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40169-018-0198-1","article-title":"The role of CD133 in cancer: A concise review","volume":"7","author":"Glumac","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2004.04.007","article-title":"Stem cell origin of cancer and differentiation therapy","volume":"51","author":"Sell","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1158\/0008-5472.CAN-08-4808","article-title":"Evidence for Cancer Stem Cells in Human Endometrial Carcinoma","volume":"69","author":"Hubbard","year":"2009","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrm2009","article-title":"Notch signalling: A simple pathway becomes complex","volume":"7","author":"Bray","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biocel.2018.12.001","article-title":"Breast cancer stem cells: Biology and therapeutic implications","volume":"107","author":"Butti","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.29800","article-title":"The Notch pathway in colorectal cancer","volume":"138","author":"Vinson","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/onc.2008.224","article-title":"The role of Notch signaling in human cervical cancer: Implications for solid tumors","volume":"27","author":"Maliekal","year":"2008","journal-title":"Oncogene"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12032-017-1039-6","article-title":"Notch signaling pathway networks in cancer metastasis: A new target for cancer therapy","volume":"34","author":"Li","year":"2017","journal-title":"Med. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-021-00206-5","article-title":"MiRNA-mediated EMT and CSCs in cancer chemoresistance","volume":"10","author":"Dong","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15384047.2016.1250985","article-title":"Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells","volume":"19","author":"Shang","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Bley, N., Hmedat, A., Muller, S., Rolnik, R., Rausch, A., Lederer, M., and Huttelmaier, S. (2021). Musashi-1-A Stemness RBP for Cancer Therapy?. Biology, 10.","DOI":"10.3390\/biology10050407"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.25856","article-title":"The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1\/CIP1","volume":"129","author":"Greve","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_61","first-page":"185","article-title":"Wnt signaling pathway in development and cancer","volume":"69","author":"Taciak","year":"2018","journal-title":"J. Physiol Pharm."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.semcdb.2010.09.004","article-title":"Wnt signaling in stem and cancer stem cells","volume":"21","author":"Wend","year":"2010","journal-title":"Semin Cell Dev. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Fatima, I., Barman, S., Rai, R., Thiel, K.W.W., and Chandra, V. (2021). Targeting Wnt Signaling in Endometrial Cancer. Cancers, 13.","DOI":"10.3390\/cancers13102351"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3892\/or.2012.2126","article-title":"Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt\/beta-catenin pathway","volume":"29","author":"Chen","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ygyno.2014.04.009","article-title":"SPARC was overexpressed in human endometrial cancer stem-like cells and promoted migration activity","volume":"134","author":"Yusuf","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3892\/ol.2012.896","article-title":"microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer","volume":"4","author":"Qin","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1010428317706217","DOI":"10.1177\/1010428317706217","article-title":"Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells","volume":"39","author":"Gong","year":"2017","journal-title":"Tumour Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"111258","DOI":"10.18632\/oncotarget.22770","article-title":"MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.febslet.2014.12.002","article-title":"MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins","volume":"589","author":"Gao","year":"2015","journal-title":"FEBS Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.7150\/jca.18869","article-title":"Expression of CD133 in endometrial cancer cells and its implications","volume":"8","author":"Ding","year":"2017","journal-title":"J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3892\/ijo.2013.2230","article-title":"Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer","volume":"44","author":"Nakamura","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.5966\/sctm.2015-0048","article-title":"Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target","volume":"4","author":"Yan","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12253-017-0320-5","article-title":"Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma","volume":"25","author":"Park","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.prp.2015.10.008","article-title":"Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer","volume":"212","author":"Elbasateeny","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2013.11.020","article-title":"Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells","volume":"345","author":"Zhang","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.18632\/oncotarget.6920","article-title":"Aldehyde dehydrogenase 1A1 in stem cells and cancer","volume":"7","author":"Tomita","year":"2016","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1349-7006.2011.01864.x","article-title":"Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications","volume":"102","author":"Rahadiani","year":"2011","journal-title":"Cancer Sci."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Kitson, S.J., Rosser, M., Fischer, D.P., Marshall, K.M., Clarke, R.B., and Crosbie, E.J. (2019). Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors. Cancers, 11.","DOI":"10.1101\/562744"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2013.03.005","article-title":"The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells","volume":"129","author":"Kusunoki","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1573403X16666200621160742","article-title":"Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer","volume":"22","author":"Talkowski","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PGP.0b013e3182055a1f","article-title":"Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma","volume":"30","author":"Zhou","year":"2011","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2017.06.070","article-title":"Preliminary identification of endometrial cancer stem cells in vitro and in vivo","volume":"490","author":"Kong","year":"2017","journal-title":"Biochem. Biophys Res. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ebiom.2018.12.044","article-title":"Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma","volume":"40","author":"Lu","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","article-title":"Epithelial\u2013mesenchymal transition in development and cancer: Role of phosphatidylinositol 3\u2032 kinase\/AKT pathways","volume":"24","author":"Larue","year":"2005","journal-title":"Oncogene"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10555-020-09882-x","article-title":"Epigenetic dynamics in cancer stem cell dormancy","volume":"39","author":"Ferrer","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","article-title":"The role of tumor stroma in cancer progression and prognosis: Emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer","volume":"6","author":"Bremnes","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Subramaniam, K.S., Tham, S.T., Mohamed, Z., Woo, Y.L., Mat Adenan, N.A., and Chung, I. (2013). Cancer-associated fibroblasts promote proliferation of endometrial cancer cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068923"},{"key":"ref_88","first-page":"200","article-title":"Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6\/STAT-3\/c-Myc pathway","volume":"6","author":"Subramaniam","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_89","first-page":"5694","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition through secreted cytokines in endometrial cancer cells","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-015-0231-4","article-title":"Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1\/CXCR4 axis","volume":"9","author":"Teng","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Walentowicz-Sadlecka, M., Sadlecki, P., Bodnar, M., Marszalek, A., Walentowicz, P., Sokup, A., Wilinska-Jankowska, A., and Grabiec, M. (2014). Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084629"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3727\/096504014X13907540404879","article-title":"Stromal cell-derived factor-1 (SDF-1)\/CXCR4 axis enhances cellular invasion in ovarian carcinoma cells via integrin beta1 and beta3 expressions","volume":"21","author":"Yu","year":"2013","journal-title":"Oncol. Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Corcoran, K.E., Trzaska, K.A., Fernandes, H., Bryan, M., Taborga, M., Srinivas, V., Packman, K., Patel, P.S., and Rameshwar, P. (2008). Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002563"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/humrep\/deg415","article-title":"Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells","volume":"18","author":"Albrecht","year":"2003","journal-title":"Hum. Reprod."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1158\/1078-0432.CCR-07-1017","article-title":"Clinical and biological significance of vascular endothelial growth factor in endometrial cancer","volume":"13","author":"Kamat","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.2147\/OTT.S132558","article-title":"The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer","volume":"10","author":"Mahecha","year":"2017","journal-title":"Onco. Targets"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1002\/cncr.25259","article-title":"Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development","volume":"116","author":"Habeeb","year":"2010","journal-title":"Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1038\/onc.2012.622","article-title":"EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF","volume":"32","author":"Gordon","year":"2013","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/IGC.0000000000000961","article-title":"Increased Endothelial Progenitor Cell Number in Early Stage of Endometrial Cancer","volume":"27","author":"Paprocka","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_100","first-page":"619","article-title":"Gene alterations in tumor-associated endothelial cells from endometrial cancer","volume":"22","author":"Du","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3892\/or.2016.4888","article-title":"Effects of estradiol on VEGF and bFGF by Akt in endometrial cancer cells are mediated through the NF-kappaB pathway","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1158\/0008-5472.CAN-03-2774","article-title":"Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation","volume":"64","author":"Seo","year":"2004","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fonc.2020.00156","article-title":"Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal-Maternal Interface","volume":"10","author":"Bruno","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Allen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fonc.2019.00421","article-title":"Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview","volume":"9","author":"Cheng","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"9731049","DOI":"10.1155\/2020\/9731049","article-title":"Endometrial Cancer Cells Promote M2-Like Macrophage Polarization by Delivering Exosomal miRNA-21 under Hypoxia Condition","volume":"2020","author":"Xiao","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2019.00877","article-title":"Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function","volume":"10","author":"Degos","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"657326","DOI":"10.3389\/fimmu.2021.657326","article-title":"Endometrial Cancer Suppresses CD8+ T Cell-Mediated Cytotoxicity in Postmenopausal Women","volume":"12","author":"Patel","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2015.10.033","article-title":"The bone marrow niche in support of breast cancer dormancy","volume":"380","author":"Walker","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s43018-020-0088-5","article-title":"The current paradigm and challenges ahead for the dormancy of disseminated tumor cells","volume":"1","author":"Risson","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/joim.12084","article-title":"Breast cancer as a systemic disease: A view of metastasis","volume":"274","author":"Redig","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1158\/0008-5472.CAN-16-1092","article-title":"Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow","volume":"76","author":"Bliss","year":"2016","journal-title":"Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/0008-5472.CAN-20-2434","article-title":"Mesenchymal Stem Cell-Secreted Extracellular Vesicles Instruct Stepwise Dedifferentiation of Breast Cancer Cells into Dormancy at the Bone Marrow Perivascular Region","volume":"81","author":"Sandiford","year":"2021","journal-title":"Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbo.2016.04.003","article-title":"Vascular niches for disseminated tumour cells in bone","volume":"5","author":"Kusumbe","year":"2016","journal-title":"J. Bone Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1152\/physiol.00025.2005","article-title":"The bone marrow vascular niche: Home of HSC differentiation and mobilization","volume":"20","author":"Kopp","year":"2005","journal-title":"Physiology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","article-title":"Molecular characterization of the tumor microenvironment in breast cancer","volume":"6","author":"Allinen","year":"2004","journal-title":"Cancer Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41556-018-0267-0","article-title":"Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy","volume":"21","author":"Carlson","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"R435","DOI":"10.1016\/j.cub.2018.01.059","article-title":"Exosomes and Ectosomes in Intercellular Communication","volume":"28","author":"Meldolesi","year":"2018","journal-title":"Curr. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Tamma, R., and Ribatti, D. (2017). Bone Niches, Hematopoietic Stem Cells, and Vessel Formation. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18010151"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1158\/0008-5472.CAN-10-2372","article-title":"Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells","volume":"71","author":"Lim","year":"2011","journal-title":"Cancer Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26508\/lsa.202000969","article-title":"Specific N-cadherin-dependent pathways drive human breast cancer dormancy in bone marrow","volume":"4","author":"Sinha","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"ref_123","first-page":"179","article-title":"Factors predicting recurrent endometrial cancer","volume":"5","author":"Huijgens","year":"2013","journal-title":"Facts Views Vis. Obgyn."},{"key":"ref_124","first-page":"22","article-title":"Endometrial cancer with bone marrow metastases: A management dilemma","volume":"9","author":"Guzha","year":"2017","journal-title":"S. Afr. J. Gynaecol. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.scr.2015.04.004","article-title":"Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression","volume":"15","author":"Wang","year":"2015","journal-title":"Stem. Cell Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/biolre\/ioy175","article-title":"Bone marrow-derived cells or C-X-C motif chemokine 12 (CXCL12) treatment improve thin endometrium in a mouse model","volume":"100","author":"Yi","year":"2019","journal-title":"Biol. Reprod."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Khatun, M., Sorjamaa, A., Kangasniemi, M., Sutinen, M., Salo, T., Liakka, A., Lehenkari, P., Tapanainen, J.S., Vuolteenaho, O., and Chen, J.C. (2017). Niche matters: The comparison between bone marrow stem cells and endometrial stem cells and stromal fibroblasts reveal distinct migration and cytokine profiles in response to inflammatory stimulus. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175986"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1095\/biolreprod.111.095885","article-title":"Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype","volume":"86","author":"Spitzer","year":"2012","journal-title":"Biol. Reprod."},{"key":"ref_129","first-page":"e94041","article-title":"Endometrial Mesenchymal Stem Cell-Derived Exosome Promote Endothelial Cell Angiogenesis in a Dose Dependent Manner: A New Perspective on Regenerative Medicine and Cell-Free Therapy","volume":"6","author":"Verdi","year":"2019","journal-title":"Arch. NeuroSci."},{"key":"ref_130","first-page":"346","article-title":"Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis","volume":"11","author":"Liu","year":"2020","journal-title":"Stem. Cell Res."},{"key":"ref_131","first-page":"225","article-title":"Exosomes derived from mesenchymal stem cells reverse EMT via TGF-beta1\/Smad pathway and promote repair of damaged endometrium","volume":"10","author":"Yao","year":"2019","journal-title":"Stem. Cell Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"bio039958","DOI":"10.1242\/bio.039958","article-title":"Exosomal transfer of bone marrow mesenchymal stem cell-derived miR-340 attenuates endometrial fibrosis","volume":"8","author":"Xiao","year":"2019","journal-title":"Biol. Open"},{"key":"ref_133","unstructured":"Morelli, S.S., Resnikoff, A.N., Haberl, J., Wojtczuk, A.S., Rameshwar, P., and Goldsmith, L.T. (2015). Bone Marrow-Derived Cells in Murine Endometrium Express Estrogen Receptor Alpha. Endocr. Rev., 36."},{"key":"ref_134","first-page":"83A","article-title":"Bone Marrow-Derived Cells in Murine Endometrium Express Estrogen Receptor Beta","volume":"22","author":"Morelli","year":"2015","journal-title":"Reprod. Sci."},{"key":"ref_135","first-page":"336A","article-title":"Bone Marrow-Derived Murine Endometrial Cells Express Progesterone Receptor","volume":"23","author":"Morelli","year":"2016","journal-title":"Reprod. Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1100\/2011\/949823","article-title":"mRNA-expression of ERalpha, ERbeta, and PR in clonal stem cell cultures obtained from human endometrial biopsies","volume":"11","author":"Schuring","year":"2011","journal-title":"Sci. World J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2009.07.037","article-title":"Notch ligand-dependent gene expression in human endometrial stromal cells","volume":"388","author":"Mikhailik","year":"2009","journal-title":"Biochem. Biophys Res. Commun."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/sci.2018.02.02","article-title":"Targeting Notch signalling pathway of cancer stem cells","volume":"5","author":"Venkatesh","year":"2018","journal-title":"Stem. Cell Investig."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","article-title":"Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways","volume":"159","author":"Boelens","year":"2014","journal-title":"Cell"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0501-y","article-title":"Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry","volume":"121","author":"Capulli","year":"2019","journal-title":"Br. J. Cancer"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/4\/714\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:21:56Z","timestamp":1760134916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/4\/714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":140,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cells11040714"],"URL":"https:\/\/doi.org\/10.3390\/cells11040714","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}